"We are delighted to announce BlueX as a licensee for our Bluetooth IP," said Aviv Malinovitch, vice president and general manager of the Connectivity Business Unit at CEVA. "CEVA's RivieraWaves Bluetooth low energy IP has gone the extra step in low power architecture, matching our technical strengths and product aims and has proven to be the perfect choice for us." "Product differentiation is always a challenge in such a competitive market and we set out to ensure our BX2400 IC outperforms the competition," said Hongyu Li, CEO at BlueX. The BlueX BX2400 SoC powered by CEVA's Bluetooth IP enables outstanding battery life and a range of compelling features and sensors, making it an ideal processor for our wearable designs." Huang Wang, founder and CEO of Huami, stated: "As the world's leading wearable technology company our customers rely on us to consistently deliver leading-edge, innovative products with exceptional performance. Ideally suited to applications such as personal health and fitness wearables, the BX2400 is already gaining strong traction with leading global OEMs and ODMs including Huami. Building on BlueX's deep expertise in CMOS subthreshold design, the BX2400 is an ultra-low power SoC that incorporates Bluetooth, processor, power charge and discharge management, touch and heart rate monitor. (BlueX) has licensed and deployed CEVA's RivieraWaves Bluetooth low energy technology in its new BX2400 Bluetooth® 5 compliant wireless integrated circuit (IC).
(NASDAQ: CEVA), the leading licensor of signal processing platforms and artificial intelligence processors for smarter, connected devices, today announced that BlueX Microelectronics ( Hefei) Co., Ltd. The 40 fund ticker symbols were PFMAX, REACX, ASVIX, ASCQX, AEPGX, AGTHX, MDLOX, BSQCX, BLUEX, DPIEX, DODGX, FAGIX, FCNTX, FDGRX, FLPSX, FMCSX, FPURX, FKIVX, GOLDX, GECMX, GSMCX, LMVTX, LLPFX, LSBDX, MSISX, PENNX, PEBIX, PYYRX, VMVXX, PRGFX, TEPLX, VIGRX, VIPSX, VINIX, VTRIX, VIMSX, VISGX, VISVX, VSEQX, and VFITX.SHANGHAI, J/PRNewswire/ - Mobile World Congress – CEVA, Inc. The correlation chart only shows the label every other fund because there are so many. The employees own over 18 million shares of INTC in the plan and it was down 13% on a 5yr APR basis. They were AEPGX 3.3%, MDLOX 11.6%, DPIEX 3.6%, GOLDX 3%, GECMX 4.3%, PEBIX 4.6%, PTTRX 17.9%, VMVXX 23.2%, VIPSX 4.6%, VTRIX 10% and VFITX 22.8% where VMVXX is a proxy for the Reserve Primary Institutional fund. The Balanced portfolio was invested in the 11 funds with positive 5yr Sharpe ratios. I also ran a scan without company stock and it had a small positve effect, the APR increased to o.77%.
Intel has over 50 funds in its plan and the top 40 in terms of employee investments plus Intel stock were in the scan. The collapse of markets worldwide in 2008 is seen in this scan. A scan with 3yr data was similar but only had three funds in the Balanced portfolio CFSAX, FGMNX and NMIRX. I also refocused the scan for a better image of the 3D design space near the Balanced portfolio. The low risk portfolio was basically in 12 funds, LQPAX 6.92%, NSTRX 12.12%, NSFAX 5.37%, COSIX 5.9%, CFSAX 12.2%, FDIVX 1.83%, FGMNX 17.22%, MCR 2.78%, VGENX 3%, VWINX 6.12% and NMIRX 21.52% where NMIRX is a proxy for the Goode stable value trust. It is possible to make lemonade out of a lemon but you do to have seek out common sense changes. This low risk portfolio is also shown in the 3D scan. I also found a portfolio with a very small standard deviation that had a decent return.
The employee asset allocation in (the 11-K date) had only a small amount invested in it and the other Balanced portfolio funds in the scan. As the 3D scan Balanced portfolio shows it is possible to get a positive 5yr return investing in government funds like FGMNX. The posted scan included almost all the mutual funds in the plan and a proxy for a Goode stable value trust but no company stock. After looking at all the funds in the plan I found a portfolio that made money. My first scan only included funds with large employee holdings and it had a 5yr negative return on top of a huge loss in company stock (BAC).